000 | 01830 a2200553 4500 | ||
---|---|---|---|
005 | 20250516022806.0 | ||
264 | 0 | _c20110725 | |
008 | 201107s 0 0 eng d | ||
022 | _a1735-9694 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShetab Boushehri, Seyed Vahid | |
245 | 0 | 0 |
_aThe C60-fullerene porphyrin adducts for prevention of the doxorubicin-induced acute cardiotoxicity in rat myocardial cells. _h[electronic resource] |
260 |
_bActa medica Iranica _c |
||
300 |
_a342-50 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenosine Triphosphate _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xtoxicity |
650 | 0 | 4 |
_aCarboxylic Acids _xchemistry |
650 | 0 | 4 | _aCell Hypoxia |
650 | 0 | 4 |
_aCreatine Kinase _xmetabolism |
650 | 0 | 4 | _aCytoprotection |
650 | 0 | 4 |
_aDoxorubicin _xtoxicity |
650 | 0 | 4 | _aDrug Carriers |
650 | 0 | 4 |
_aEnergy Metabolism _xdrug effects |
650 | 0 | 4 |
_aFullerenes _xchemistry |
650 | 0 | 4 | _aHydrogen-Ion Concentration |
650 | 0 | 4 | _aLethal Dose 50 |
650 | 0 | 4 |
_aMagnesium _xchemistry |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMetal Nanoparticles |
650 | 0 | 4 |
_aMitochondria, Heart _xdrug effects |
650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
650 | 0 | 4 |
_aOxygen Consumption _xdrug effects |
650 | 0 | 4 |
_aPorphyrins _xchemistry |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 | _aSurface Properties |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aOstad, Seyed Nasser | |
700 | 1 | _aSarkar, Saeed | |
700 | 1 | _aKuznetsov, Dmitry A | |
700 | 1 | _aBuchachenko, Anatoly L | |
700 | 1 | _aOrlova, Marina A | |
700 | 1 | _aMinaii, Bagher | |
700 | 1 | _aKebriaeezadeh, Abbas | |
700 | 1 | _aRezayat, Seyed Mahdi | |
773 | 0 |
_tActa medica Iranica _gvol. 48 _gno. 5 _gp. 342-50 |
|
999 |
_c20566437 _d20566437 |